Palvella Therapeutics (PVLA) Leases (2019 - 2023)
Historic Leases for Palvella Therapeutics (PVLA) over the last 5 years, with Q2 2023 value amounting to $3.8 million.
- Palvella Therapeutics' Leases rose 550.18% to $3.8 million in Q2 2023 from the same period last year, while for Jun 2023 it was $3.8 million, marking a year-over-year increase of 550.18%. This contributed to the annual value of $3.7 million for FY2022, which is 521.87% down from last year.
- Palvella Therapeutics' Leases amounted to $3.8 million in Q2 2023, which was up 550.18% from $3.8 million recorded in Q1 2023.
- Palvella Therapeutics' 5-year Leases high stood at $4.0 million for Q3 2021, and its period low was $3.2 million during Q1 2020.
- For the 5-year period, Palvella Therapeutics' Leases averaged around $3.7 million, with its median value being $3.8 million (2021).
- In the last 5 years, Palvella Therapeutics' Leases skyrocketed by 1952.68% in 2021 and then plummeted by 1446.9% in 2022.
- Palvella Therapeutics' Leases (Quarter) stood at $3.4 million in 2019, then rose by 14.49% to $3.9 million in 2020, then dropped by 0.64% to $3.9 million in 2021, then fell by 5.22% to $3.7 million in 2022, then increased by 3.0% to $3.8 million in 2023.
- Its last three reported values are $3.8 million in Q2 2023, $3.8 million for Q1 2023, and $3.7 million during Q4 2022.